Search research articles
Contact Us
Filters
Showing results (211-220 of 283) with videos related to
Page
of 29
Sort By:
JAMA Oncology
|
July 25, 2024
Atezolizumab Before and After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase II Nonrandomized Controlled Trial
Helen J Ross, David Kozono, Xiaofei F Wang, et al.
Oncoimmunology
|
February 21, 2025
Evaluating the effect of immune checkpoint inhibitor treatment on chronic obstructive pulmonary disease in lung cancer patients
Anet Greib, Songzhu Zhao, Michelle Ploch, et al.
Nature Communications
|
July 31, 2021
AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicing
Georgios I Laliotis, Evangelia Chavdoula, Maria D Paraskevopoulou, et al.
British Journal of Cancer
|
October 17, 2022
Utility of cell-free DNA from bronchial washing fluid in diagnosis and genomic determination for radiology-suspected pulmonary nodules
Xinyu Zhang, Zhuo Yu, Yaping Xu, et al.
Biorxiv : the Preprint Server for Biology
|
June 3, 2024
An <i>in vivo</i> "turning model" reveals new RanBP9 interactions in lung macrophages
Yasuko Kajimura, Anna Tessari, Arturo Orlacchio, et al.
Nature Communications
|
June 28, 2022
Retraction Note: AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicing
Georgios I Laliotis, Evangelia Chavdoula, Maria D Paraskevopoulou, et al.
Journal of Geriatric Oncology
|
February 25, 2021
Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancer
Andrew C Johns, Lai Wei, Madison Grogan, et al.
Science Translational Medicine
|
January 28, 2026
SREBP-1 increases glucose uptake to promote tumor resistance to lysosome inhibition
Yaogang Zhong, Feng Geng, Huali Su, et al.
Molecular & Cellular Proteomics : MCP
|
July 5, 2012
In-depth proteomic analysis of nonsmall cell lung cancer to discover molecular targets and candidate biomarkers
Takefumi Kikuchi, Mohamed Hassanein, Joseph M Amann, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 15, 2025
Impact of immune-related and non-immune related hospital admissions on survival of patients with non-small cell lung cancer receiving first-line immunotherapy
Adam Khorasanchi, Mingjia Li, Songzhu Zhao, et al.
Page
of 29
Search research articles
Search
Showing results (211-220 of 283) with videos related to
Sort By:
Page
of 29
JAMA Oncology
|
July 25, 2024
Atezolizumab Before and After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase II Nonrandomized Controlled Trial
Helen J Ross, David Kozono, Xiaofei F Wang, et al.
Oncoimmunology
|
February 21, 2025
Evaluating the effect of immune checkpoint inhibitor treatment on chronic obstructive pulmonary disease in lung cancer patients
Anet Greib, Songzhu Zhao, Michelle Ploch, et al.
Nature Communications
|
July 31, 2021
AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicing
Georgios I Laliotis, Evangelia Chavdoula, Maria D Paraskevopoulou, et al.
British Journal of Cancer
|
October 17, 2022
Utility of cell-free DNA from bronchial washing fluid in diagnosis and genomic determination for radiology-suspected pulmonary nodules
Xinyu Zhang, Zhuo Yu, Yaping Xu, et al.
Biorxiv : the Preprint Server for Biology
|
June 3, 2024
An <i>in vivo</i> "turning model" reveals new RanBP9 interactions in lung macrophages
Yasuko Kajimura, Anna Tessari, Arturo Orlacchio, et al.
Nature Communications
|
June 28, 2022
Retraction Note: AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicing
Georgios I Laliotis, Evangelia Chavdoula, Maria D Paraskevopoulou, et al.
Journal of Geriatric Oncology
|
February 25, 2021
Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancer
Andrew C Johns, Lai Wei, Madison Grogan, et al.
Science Translational Medicine
|
January 28, 2026
SREBP-1 increases glucose uptake to promote tumor resistance to lysosome inhibition
Yaogang Zhong, Feng Geng, Huali Su, et al.
Molecular & Cellular Proteomics : MCP
|
July 5, 2012
In-depth proteomic analysis of nonsmall cell lung cancer to discover molecular targets and candidate biomarkers
Takefumi Kikuchi, Mohamed Hassanein, Joseph M Amann, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 15, 2025
Impact of immune-related and non-immune related hospital admissions on survival of patients with non-small cell lung cancer receiving first-line immunotherapy
Adam Khorasanchi, Mingjia Li, Songzhu Zhao, et al.
Page
of 29